Asia Pacific In-Vitro Diagnostics Market Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)
The Asia Pacific in-vitro diagnostics market is expected to grow from US$ 19,109.18 million in 2022 to US$ 30,943.27 million by 2030. It is estimated to grow at a CAGR of 6.2% from 2022 to 2030.
Integration of IVD Technologies with Digital Health Solutions Fuels Asia Pacific In-Vitro Diagnostics Market
IVD is used in clinical, laboratory, and outpatient settings with the aim specifically to help in the detection of diseases and, consequently, aid in the selection of appropriate treatment protocols. The integration of IVD technologies with digital health solutions is gaining traction globally. Data analytics, artificial Intelligence, and remote monitoring enhance the value of diagnostic tests, leading to better patient management and outcomes. IVD technologies integrated with digital health solutions can be incorporated into clinical decision support systems. As recognized by the WHO, digital health solutions could help detect diseases. Artificial intelligence health bots and similar other emerging solutions may present opportunities for patient care and address challenges such as high cost and time requirements. In diagnostics based on genomic testing, deep learning can identify cancer cells, determine their type, and predict what mutations may occur in a tumor from images of a specific sample. Artificial intelligence and machine learning (AI/ML) in in-vitro diagnostics are revolutionizing medical device development. These modern diagnostic systems facilitate diagnosis based on digital image analysis, thereby improving healthcare decision-making. Smart diagnostics are extremely scalable IVD solutions that use artificial intelligence to perform better than lab-based diagnostics at a fraction of the price. Additionally, this type of diagnostics can derive emergent features through unique chemical and biological signature detection and analysis. Thus, the integration of IVD with digital health technologies is likely to offer lucrative opportunities to the in-vitro diagnostics market in the coming years.
Asia Pacific In-Vitro Diagnostics Market Overview
The Asia Pacific in-vitro diagnostics market has been segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in China is high attributed to the rising awareness of the disease diagnosis. India holds third largest share in terms of in-vitro diagnostics owing to high prevalence of diseases across the country. The aforementioned factors are responsible for influential growth of in-vitro diagnostics market in the Asia Pacific region. There has been a growth in cancer incidence and mortality rates in China, which has made cancer the primary cause of death in the last decade in the country. The majority of the increasing cases are due to population growth (particularly an upsurge in the elderly population) and socio-demographic changes. Q2 Solutions, a clinical trial laboratory services organization, collaborated with Guangzhou KingMed Diagnostics to develop in-vitro diagnostics products and companion diagnostics (CDx) for the Chinese market. Moreover, several players are investing in the expansion of the cancer biomarkers market. In August 2018, Ipsos’ Healthcare Service Line launched the syndicated lab mapping study and oncology molecular diagnostics (MDx) monitor. These two studies will offer comprehensive oncology biomarker testing in China’s tier I and tier II cities.
Asia Pacific In-Vitro Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific In-Vitro Diagnostics Market Segmentation
The Asia Pacific in-vitro diagnostics market is segmented into product & services, technology, application, end user, and country.
Based on product & services, the Asia Pacific in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held the largest share of the Asia Pacific in-vitro diagnostics market in 2022.
Based on technology, the Asia Pacific in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held the largest share of the Asia Pacific in-vitro diagnostics market in 2022.
Based on application, the Asia Pacific in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held the largest share of the Asia Pacific in-vitro diagnostics market in 2022.
Based on end user, the Asia Pacific in-vitro diagnostics market is segmented into hospitals, laboratories, homecare, and others. The hospitals segment held the largest share of the Asia Pacific in-vitro diagnostics market in 2022.
Based on country, the Asia Pacific in-vitro diagnostics market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific in-vitro diagnostics market in 2022.
Abbott Laboratories, Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Qiagen NV, Siemens AG, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific in-vitro diagnostics market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific In-Vitro Diagnostics Market - Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Prevalence of Chronic and Infectious Diseases
4.1.2 Growth in Point-of-Care Testing and Surge in Demand for IVD during COVID-19 Pandemic
4.2 Market Restraint
4.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
4.3 Market Opportunities
4.3.1 Integration of IVD with Digital Health Technologies
4.4 Future Trends
4.4.1 Increasing Demand for Personalized Medicine and Genomics
5. Asia Pacific In-Vitro Diagnostics Market - Global Market Analysis
5.1 Asia Pacific In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 – 2030
6. Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services
6.1 Overview
6.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
6.3 Reagents and Kits
6.3.1 Overview
6.3.2 Reagents and Kits: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Software and Services
6.4.1 Overview
6.4.2 Software and Services: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Instruments
6.5.1 Overview
6.5.2 Instruments: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Technology
7.1 Overview
7.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
7.3 Immunoassay/ Immunochemistry
7.3.1 Overview
7.3.2 Immunoassay/ Immunochemistry: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Clinical Chemistry
7.4.1 Overview
7.4.2 Clinical Chemistry: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Molecular Diagnostics
7.5.1 Overview
7.5.2 Molecular Diagnostics: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Microbiology
7.6.1 Overview
7.6.2 Microbiology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Blood Glucose Self-Monitoring
7.7.1 Overview
7.7.2 Blood Glucose Self-Monitoring: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Coagulation and Hemostasis
7.8.1 Overview
7.8.2 Coagulation and Hemostasis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Hematology
7.9.1 Overview
7.9.2 Hematology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.10 Urinalysis
7.10.1 Overview
7.10.2 Urinalysis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Infectious Disease
8.3.1 Overview
8.3.2 Infectious Diseases: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Diabetes
8.4.1 Overview
8.4.2 Diabetes: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Oncology
8.5.1 Overview
8.5.2 Oncology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Autoimmune Diseases
8.7.1 Overview
8.7.2 Autoimmune Diseases: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Nephrology
8.8.1 Overview
8.8.2 Nephrology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Laboratories
9.4.1 Overview
9.4.2 Laboratories: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Asia Pacific In-Vitro Diagnostics Market
10.1.1 Overview
10.1.2 Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Country
10.1.2.1 China: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 China: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.1.4 China: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.1.5 China: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.1.6 China: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.2 Japan: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 Japan: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.2.4 Japan: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.2.5 Japan: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.2.6 Japan: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.3 India: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 India: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.3.4 India: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.3.5 India: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.3.6 India: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.4 Australia: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Australia: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.3 Australia: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.4.4 Australia: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.4.5 Australia: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.4.6 Australia: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.5 South Korea: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 South Korea: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.3 South Korea: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.5.4 South Korea: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.5.5 South Korea: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.5.6 South Korea: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.6 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.6.3 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.6.4 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.6.5 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.6.6 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11. Industry Landscape
11.1 Organic Developments
11.1.1 Overview
11.2 Inorganic Developments
11.2.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Siemens AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Becton Dickinson and Co
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 bioMerieux SA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Bio-Rad Laboratories Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Qiagen NV
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific In-Vitro Diagnostics Market Segmentation
Table 2. Death Rate Of Cancer in 2020 Globally
Table 3. China Asia Pacific In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 4. China Asia Pacific In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 5. China Asia Pacific In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. China Asia Pacific In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan Asia Pacific In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan Asia Pacific In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan Asia Pacific In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan Asia Pacific In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 11. India Asia Pacific In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 12. India Asia Pacific In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 13. India Asia Pacific In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 14. India Asia Pacific In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia Asia Pacific In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia Asia Pacific In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 17. Australia Asia Pacific In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 18. Australia Asia Pacific In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea Asia Pacific In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea Asia Pacific In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 21. South Korea Asia Pacific In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 22. South Korea Asia Pacific In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific Asia Pacific In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Asia Pacific Asia Pacific In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Asia Pacific Asia Pacific In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 26. Rest of Asia Pacific Asia Pacific In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 27. Organic Developments Done by Companies
Table 28. Inorganic Developments Done by Companies
Table 29. Glossary of Terms, Asia Pacific In-Vitro Diagnostics Market
List of Figures
Figure 1. Asia Pacific In-Vitro Diagnostics Market Segmentation, By Country
Figure 2. Asia Pacific In-Vitro Diagnostics Market: Key Industry Dynamics
Figure 3. Asia Pacific In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 6. Reagents and Kits: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Software and Services: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Instruments: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 10. Immunoassay/ Immunochemistry: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Clinical Chemistry: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular Diagnostics: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Microbiology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Blood Glucose Self-Monitoring: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Coagulation and Hemostasis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Hematology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Urinalysis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
Figure 20. Infectious Diseases: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Diabetes: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Oncology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Cardiology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Autoimmune Diseases: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Nephrology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Asia Pacific In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Laboratories: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Homecare: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Asia Pacific In-Vitro Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 33. Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 34. China: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Japan: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. India: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Australia: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. South Korea: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- Abbott Laboratories
- Becton Dickinson and Co
- bioMerieux SA
- Bio-Rad Laboratories Inc
- Danaher Corp
- F. Hoffmann-La Roche Ltd
- Qiagen NV
- Siemens AG
- Thermo Fisher Scientific Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific In-Vitro Diagnostics Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific In-Vitro Diagnostics Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.